Literature DB >> 1662423

Receptors for neuropeptide Y: multiple subtypes and multiple second messengers.

M C Michel1.   

Abstract

Neuropeptide Y (NPY) can elicit numerous physiological responses by activating specific pre- and postsynaptic receptors. Different orders of potency for agonists in various model systems suggest that there are multiple subtypes of NPY receptors, described here by Martin Michel, but their pharmacological definition remains tentative, awaiting development of specific antagonists and receptor cloning studies. The coupling of NPY receptors to various signal transduction mechanisms is also reviewed, including inhibition of adenylyl cyclase and stimulation or inhibition of increases in intracellular Ca2+, but a link between individual NPY receptor subtypes and specific signal transduction pathways has not been established.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1662423     DOI: 10.1016/0165-6147(91)90610-5

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  39 in total

1.  Substitution of D-Trp32 in NPY destabilizes the binding transition state to the Y1 receptor site in SK-N-MC cell membranes.

Authors:  R Zand; C L Marcelo; R MacKenzie; L Georgic; D Maclean; W R Dunham
Journal:  Neurochem Res       Date:  1997-04       Impact factor: 3.996

Review 2.  Role of the sympathetic nervous system in chronic joint pain and inflammation.

Authors:  B L Kidd; S Cruwys; P I Mapp; D R Blake
Journal:  Ann Rheum Dis       Date:  1992-11       Impact factor: 19.103

3.  Effects of noradrenaline and neuropeptide Y on rat mesenteric microvessel contraction.

Authors:  H Chen; C Fetscher; R F Schäfers; G Wambach; T Philipp; M C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-02       Impact factor: 3.000

4.  A review of FMRFamide- and RFamide-like peptides in metazoa.

Authors:  Robert J Walker; Sylvana Papaioannou; Lindy Holden-Dye
Journal:  Invert Neurosci       Date:  2010-02-26

5.  Neuropeptide Y is a prejunctional inhibitor of vagal but not sympathetic inotropic responses in guinea-pig isolated left atria.

Authors:  A P Serone; J A Angus
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

6.  Neuropeptide Y signaling in the central nucleus of amygdala regulates alcohol-drinking and anxiety-like behaviors of alcohol-preferring rats.

Authors:  Huaibo Zhang; Amul J Sakharkar; Guangbin Shi; Rajesh Ugale; Anand Prakash; Subhash C Pandey
Journal:  Alcohol Clin Exp Res       Date:  2009-12-18       Impact factor: 3.455

7.  Vasoconstrictor effects of various neuropeptide Y analogues on the rat tail artery in the presence of phenylephrine.

Authors:  M Tschöpl; R C Miller; J Pelton; J C Stoclet; B Bucher
Journal:  Br J Pharmacol       Date:  1993-11       Impact factor: 8.739

8.  Inhibition of nicotinic acetylcholine receptor channels in bovine adrenal chromaffin cells by Y3-type neuropeptide Y receptors via the adenylate cyclase/protein kinase A system.

Authors:  W Nörenberg; M Bek; N Limberger; K Takeda; P Illes
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-04       Impact factor: 3.000

9.  Mechanisms underlying the insulinostatic effect of peptide YY in mouse pancreatic islets.

Authors:  A G Nieuwenhuizen; S Karlsson; T Fridolf; B Ahrén
Journal:  Diabetologia       Date:  1994-09       Impact factor: 10.122

10.  Effects of neuropeptide Y on L-type calcium current in guinea-pig ventricular myocytes.

Authors:  S M Bryant; G Hart
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.